Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Eicosapentaenoic acid and/or aspirin for preventing colorectal adenomas during colonoscopic surveillance in the NHS Bowel Cancer Screening Programme: the seAFOod RCT.

Hull MA, Sprange K, Hepburn T, Tan W, Shafayat A, Rees CJ, Clifford G, Logan RF, Loadman PM, Williams EA, Whitham D, Montgomery AA.

Southampton (UK): NIHR Journals Library; 2019 Jun.

2.

Attitudes to out-of-programme experiences, research and academic training of gastroenterology trainees between 2007 and 2016.

McFarlane M, Bhala N, China L, Alrubaiy L, Chedgy F, Disney BR, Farmer AD, Fogden E, Sadler G, Hull MA, McLaughlin J, Ellison H, Solomon J, Brookes MJ.

Frontline Gastroenterol. 2019 Jan;10(1):57-66. doi: 10.1136/flgastro-2018-100993. Epub 2018 Jun 19.

PMID:
30651959
3.

Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance).

Song M, Ou FS, Zemla TJ, Hull MA, Shi Q, Limburg PJ, Alberts SR, Sinicrope FA, Giovannucci EL, Van Blarigan EL, Meyerhardt JA, Chan AT.

Int J Cancer. 2019 Jul 15;145(2):380-389. doi: 10.1002/ijc.32113. Epub 2019 Jan 28.

PMID:
30623420
4.

Decreasing Risk of First and Subsequent Surgeries in Patients With Crohn's Disease in England From 1994 through 2013.

Burr NE, Lord R, Hull MA, Subramanian V.

Clin Gastroenterol Hepatol. 2019 Sep;17(10):2042-2049.e4. doi: 10.1016/j.cgh.2018.12.022. Epub 2018 Dec 21.

PMID:
30583051
5.

Eicosapentaenoic acid and aspirin, alone and in combination, for the prevention of colorectal adenomas (seAFOod Polyp Prevention trial): a multicentre, randomised, double-blind, placebo-controlled, 2 × 2 factorial trial.

Hull MA, Sprange K, Hepburn T, Tan W, Shafayat A, Rees CJ, Clifford G, Logan RF, Loadman PM, Williams EA, Whitham D, Montgomery AA; seAFOod Collaborative Group.

Lancet. 2018 Dec 15;392(10164):2583-2594. doi: 10.1016/S0140-6736(18)31775-6. Epub 2018 Nov 19.

6.

Cancer risk after bariatric surgery - is colorectal cancer a special case?

Hull MA, Markar SR, Morris EJA.

Nat Rev Gastroenterol Hepatol. 2018 Nov;15(11):653-654. doi: 10.1038/s41575-018-0070-1. No abstract available.

PMID:
30267023
7.

Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer.

Volpato M, Hull MA.

Cancer Metastasis Rev. 2018 Sep;37(2-3):545-555. doi: 10.1007/s10555-018-9744-y. Review.

8.

Reply.

Subramanian V, Burr NE, Hull MA.

Clin Gastroenterol Hepatol. 2018 Oct;16(10):1680-1681. doi: 10.1016/j.cgh.2018.06.006. Epub 2018 Jul 2. No abstract available.

9.

Obesity surgery and risk of colorectal and other obesity-related cancers: An English population-based cohort study.

Aravani A, Downing A, Thomas JD, Lagergren J, Morris EJA, Hull MA.

Cancer Epidemiol. 2018 Apr;53:99-104. doi: 10.1016/j.canep.2018.01.002. Epub 2018 Feb 3.

10.

Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer.

Lawler M, Alsina D, Adams RA, Anderson AS, Brown G, Fearnhead NS, Fenwick SW, Halloran SP, Hochhauser D, Hull MA, Koelzer VH, McNair AGK, Monahan KJ, Näthke I, Norton C, Novelli MR, Steele RJC, Thomas AL, Wilde LM, Wilson RH, Tomlinson I; Bowel Cancer UK Critical Research Gaps in Colorectal Cancer Initiative.

Gut. 2018 Jan;67(1):179-193. doi: 10.1136/gutjnl-2017-315333. Review.

11.

A novel bioactive derivative of eicosapentaenoic acid (EPA) suppresses intestinal tumor development in ApcΔ14/+ mice.

Nakanishi M, Hanley MP, Zha R, Igarashi Y, Hull MA, Mathias G, Sciavolino F, Grady JJ, Rosenberg DW.

Carcinogenesis. 2018 Mar 8;39(3):429-438. doi: 10.1093/carcin/bgx136.

12.

Increasing Prescription of Opiates and Mortality in Patients With Inflammatory Bowel Diseases in England.

Burr NE, Smith C, West R, Hull MA, Subramanian V.

Clin Gastroenterol Hepatol. 2018 Apr;16(4):534-541.e6. doi: 10.1016/j.cgh.2017.10.022. Epub 2017 Nov 26.

PMID:
29079223
13.

A randomised trial of the effect of omega-3 polyunsaturated fatty acid supplements on the human intestinal microbiota.

Watson H, Mitra S, Croden FC, Taylor M, Wood HM, Perry SL, Spencer JA, Quirke P, Toogood GJ, Lawton CL, Dye L, Loadman PM, Hull MA.

Gut. 2018 Nov;67(11):1974-1983. doi: 10.1136/gutjnl-2017-314968. Epub 2017 Sep 26.

14.

Development and Psychometric Testing of the Diabetes Caregiver Activity and Support Scale.

Scarton LJ, Bakas T, Miller WR, McLennon SM, Huber LL, Hull MA.

Diabetes Educ. 2017 Oct;43(5):465-475. doi: 10.1177/0145721717726280. Epub 2017 Aug 22.

PMID:
28828937
15.

Paracrine cyclooxygenase-2 activity by macrophages drives colorectal adenoma progression in the Apc Min/+ mouse model of intestinal tumorigenesis.

Hull MA, Cuthbert RJ, Ko CWS, Scott DJ, Cartwright EJ, Hawcroft G, Perry SL, Ingram N, Carr IM, Markham AF, Bonifer C, Coletta PL.

Sci Rep. 2017 Jul 20;7(1):6074. doi: 10.1038/s41598-017-06253-5.

16.

A liquid chromatography-tandem mass spectrometry method to measure fatty acids in biological samples.

Volpato M, Spencer JA, Race AD, Munarini A, Belluzzi A, Cockbain AJ, Hull MA, Loadman PM.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Jun 15;1055-1056:125-134. doi: 10.1016/j.jchromb.2017.04.030. Epub 2017 Apr 24.

17.

Improved local control with an aggressive strategy of preoperative (with or without intraoperative) radiation therapy combined with radical surgical resection for retroperitoneal sarcoma.

Hull MA, Molina G, Niemierko A, Haynes AB, Jacobson A, Bernstein KA, Chen YL, DeLaney TF, Mullen JT.

J Surg Oncol. 2017 May;115(6):746-751. doi: 10.1002/jso.24557. Epub 2017 Jan 27.

PMID:
28127762
18.

Measurement of red blood cell eicosapentaenoic acid (EPA) levels in a randomised trial of EPA in patients with colorectal cancer liver metastases.

Watson H, Cockbain AJ, Spencer J, Race A, Volpato M, Loadman PM, Toogood GJ, Hull MA.

Prostaglandins Leukot Essent Fatty Acids. 2016 Dec;115:60-66. doi: 10.1016/j.plefa.2016.10.003. Epub 2016 Oct 7.

19.

Colorectal Cancer Prognosis Following Obesity Surgery in a Population-Based Cohort Study.

Tao W, Konings P, Hull MA, Adami HO, Mattsson F, Lagergren J.

Obes Surg. 2017 May;27(5):1233-1239. doi: 10.1007/s11695-016-2431-6.

20.

Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma.

Molina G, Hull MA, Chen YL, DeLaney TF, De Amorim Bernstein K, Choy E, Cote G, Harmon DC, Mullen JT, Haynes AB.

J Surg Oncol. 2016 Dec;114(7):814-820. doi: 10.1002/jso.24427. Epub 2016 Sep 16.

PMID:
27634478
21.

Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?

Walsh E, Rees CJ, Gill M, Parker CE, Bevan R, Perry SL, Bury Y, Mills S, Bradburn DM, Bramble M, Hull MA.

Br J Cancer. 2016 Jul 12;115(2):261-5. doi: 10.1038/bjc.2016.159. Epub 2016 May 24.

22.

Changes in plasma chemokine C-C motif ligand 2 levels during treatment with eicosapentaenoic acid predict outcome in patients undergoing surgery for colorectal cancer liver metastasis.

Volpato M, Perry SL, Marston G, Ingram N, Cockbain AJ, Burghel H, Mann J, Lowes D, Wilson E, Droop A, Randerson-Moor J, Coletta PL, Hull MA.

Oncotarget. 2016 May 10;7(19):28139-50. doi: 10.18632/oncotarget.8579.

23.

Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?

Burr NE, Hull MA, Subramanian V.

World J Gastroenterol. 2016 Apr 7;22(13):3679-86. doi: 10.3748/wjg.v22.i13.3679. Review.

24.

Folic Acid Supplementation May Reduce Colorectal Cancer Risk in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.

Burr NE, Hull MA, Subramanian V.

J Clin Gastroenterol. 2017 Mar;51(3):247-253. doi: 10.1097/MCG.0000000000000498. Review.

PMID:
26905603
25.

The Pharmacokinetic Profile of a New Gastroresistant Capsule Preparation of Eicosapentaenoic Acid as the Free Fatty Acid.

Scaioli E, Cardamone C, Liverani E, Munarini A, Hull MA, Belluzzi A.

Biomed Res Int. 2015;2015:360825. doi: 10.1155/2015/360825. Epub 2015 Aug 3.

26.

Post-operative renal function following nephrectomy as part of en bloc resection of retroperitoneal sarcoma (RPS).

Hull MA, Niemierko A, Haynes AB, Jacobson A, Chen YL, DeLaney TF, Mullen JT.

J Surg Oncol. 2015 Jul;112(1):98-102. doi: 10.1002/jso.23949. Epub 2015 Jul 14.

PMID:
26179132
27.

Needs and Concerns of Family Caregivers of American Indians, African Americans, and Caucasians With Type 2 Diabetes.

Scarton LJ, Bakas T, Poe GD, Hull MA, Ongwela LA, Miller WR.

Clin Nurs Res. 2016 Apr;25(2):139-56. doi: 10.1177/1054773814562879. Epub 2014 Dec 12.

PMID:
25505159
28.

Successful delivery of clinical gastroenterology studies in the UK.

Hull MA, McLaughlin JT.

Gut. 2015 May;64(5):854-6. doi: 10.1136/gutjnl-2014-308348. Epub 2014 Nov 6. No abstract available.

29.

Screen-detected colorectal cancers are associated with an improved outcome compared with stage-matched interval cancers.

Gill MD, Bramble MG, Hull MA, Mills SJ, Morris E, Bradburn DM, Bury Y, Parker CE, Lee TJ, Rees CJ.

Br J Cancer. 2014 Nov 25;111(11):2076-81. doi: 10.1038/bjc.2014.498. Epub 2014 Sep 23.

30.

Mortality associated with laparotomy-confirmed neonatal spontaneous intestinal perforation: a prospective 5-year multicenter analysis.

Fisher JG, Jones BA, Gutierrez IM, Hull MA, Kang KH, Kenny M, Zurakowski D, Modi BP, Horbar JD, Jaksic T.

J Pediatr Surg. 2014 Aug;49(8):1215-9. doi: 10.1016/j.jpedsurg.2013.11.051. Epub 2013 Nov 15.

PMID:
25092079
31.

Citrulline levels following proximal versus distal small bowel resection.

Gutierrez IM, Fisher JG, Ben-Ishay O, Jones BA, Kang KH, Hull MA, Shillingford N, Zurakowski D, Modi BP, Jaksic T.

J Pediatr Surg. 2014 May;49(5):741-4. doi: 10.1016/j.jpedsurg.2014.02.056. Epub 2014 Feb 22.

PMID:
24851760
32.

Eicosapentaenoic acid free fatty acid prevents and suppresses colonic neoplasia in colitis-associated colorectal cancer acting on Notch signaling and gut microbiota.

Piazzi G, D'Argenio G, Prossomariti A, Lembo V, Mazzone G, Candela M, Biagi E, Brigidi P, Vitaglione P, Fogliano V, D'Angelo L, Fazio C, Munarini A, Belluzzi A, Ceccarelli C, Chieco P, Balbi T, Loadman PM, Hull MA, Romano M, Bazzoli F, Ricciardiello L.

Int J Cancer. 2014 Nov 1;135(9):2004-13. doi: 10.1002/ijc.28853. Epub 2014 Mar 28.

33.

Anticolorectal cancer activity of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid.

Cockbain AJ, Volpato M, Race AD, Munarini A, Fazio C, Belluzzi A, Loadman PM, Toogood GJ, Hull MA.

Gut. 2014 Nov;63(11):1760-8. doi: 10.1136/gutjnl-2013-306445. Epub 2014 Jan 27.

PMID:
24470281
34.

Mortality and management of surgical necrotizing enterocolitis in very low birth weight neonates: a prospective cohort study.

Hull MA, Fisher JG, Gutierrez IM, Jones BA, Kang KH, Kenny M, Zurakowski D, Modi BP, Horbar JD, Jaksic T.

J Am Coll Surg. 2014 Jun;218(6):1148-55. doi: 10.1016/j.jamcollsurg.2013.11.015. Epub 2013 Nov 27.

PMID:
24468227
35.

Commentary: the association between low-dose aspirin use and the incidence of colorectal cancer.

Burr N, Hull MA.

Aliment Pharmacol Ther. 2013 Sep;38(6):653-4. doi: 10.1111/apt.12437. No abstract available.

36.

MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion.

Verghese ET, Drury R, Green CA, Holliday DL, Lu X, Nash C, Speirs V, Thorne JL, Thygesen HH, Zougman A, Hull MA, Hanby AM, Hughes TA.

J Pathol. 2013 Nov;231(3):388-99. doi: 10.1002/path.4248.

38.

Reduced type II interleukin-4 receptor signalling drives initiation, but not progression, of colorectal carcinogenesis: evidence from transgenic mouse models and human case-control epidemiological observations.

Ingram N, Northwood EL, Perry SL, Marston G, Snowden H, Taylor JC, Scott N, Bishop DT, Coletta PL, Hull MA.

Carcinogenesis. 2013 Oct;34(10):2341-9. doi: 10.1093/carcin/bgt222. Epub 2013 Jun 19.

39.

Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypass.

Kant P, Perry SL, Dexter SP, Race AD, Loadman PM, Hull MA.

Obesity (Silver Spring). 2014 Jan;22(1):202-10. doi: 10.1002/oby.20493.

40.

Increased risk of colorectal cancer after obesity surgery.

Derogar M, Hull MA, Kant P, Östlund M, Lu Y, Lagergren J.

Ann Surg. 2013 Dec;258(6):983-8. doi: 10.1097/SLA.0b013e318288463a.

41.

Regional differences in prostaglandin E₂ metabolism in human colorectal cancer liver metastases.

Young AL, Chalmers CR, Hawcroft G, Perry SL, Treanor D, Toogood GJ, Jones PF, Hull MA.

BMC Cancer. 2013 Feb 26;13:92. doi: 10.1186/1471-2407-13-92.

42.

Report of 111 consecutive patients enrolled in the International Serial Transverse Enteroplasty (STEP) Data Registry: a retrospective observational study.

Jones BA, Hull MA, Potanos KM, Zurakowski D, Fitzgibbons SC, Ching YA, Duggan C, Jaksic T, Kim HB; International STEP Data Registry.

J Am Coll Surg. 2013 Mar;216(3):438-46. doi: 10.1016/j.jamcollsurg.2012.12.018. Epub 2013 Jan 26.

43.

Nutritional agents with anti-inflammatory properties in chemoprevention of colorectal neoplasia.

Hull MA.

Recent Results Cancer Res. 2013;191:143-56. doi: 10.1007/978-3-642-30331-9_8. Review.

PMID:
22893204
44.

FGFR1-induced epithelial to mesenchymal transition through MAPK/PLCγ/COX-2-mediated mechanisms.

Tomlinson DC, Baxter EW, Loadman PM, Hull MA, Knowles MA.

PLoS One. 2012;7(6):e38972. doi: 10.1371/journal.pone.0038972. Epub 2012 Jun 12.

45.

Aspirin users attending for NHS bowel cancer screening have less colorectal neoplasia: chemoprevention or false-positive faecal occult blood testing?

Lee TJ, Hull MA, Rajasekhar PT, Clifford GM, Ritchie M, James P, McNally RJ, Rutter MD, Rees CJ.

Digestion. 2012;85(4):278-81. doi: 10.1159/000334372. Epub 2012 Apr 24.

PMID:
22538301
46.

Getting involved in clinical trials research in the UK: how can Clinical Research Networks help?

Hull MA, Yiannakou Y, Gower J, Ryder SD, Bloom SL, Rees CR.

Frontline Gastroenterol. 2012 Apr;3(2):66-71. doi: 10.1136/flgastro-2011-100083. Epub 2012 Jan 10. Review.

47.

Randomized trial comparing 2 fiber regimens for the reduction of symptoms of constipation.

Hull MA, McIntire DD, Atnip SD, Dreadin J, Nihira MA, Drewes PG, Schaffer JI, Wai CY.

Female Pelvic Med Reconstr Surg. 2011 May;17(3):128-33. doi: 10.1097/SPV.0b013e31821a8b4d.

PMID:
22453784
48.

Faecal calprotectin levels before and after weight loss in obese and overweight subjects.

Kant P, Fazakerley R, Hull MA.

Int J Obes (Lond). 2013 Feb;37(2):317-9. doi: 10.1038/ijo.2012.38. Epub 2012 Mar 13.

PMID:
22410961
49.

The omega-3 polyunsaturated fatty acid eicosapentaenoic acid inhibits mouse MC-26 colorectal cancer cell liver metastasis via inhibition of PGE2-dependent cell motility.

Hawcroft G, Volpato M, Marston G, Ingram N, Perry SL, Cockbain AJ, Race AD, Munarini A, Belluzzi A, Loadman PM, Coletta PL, Hull MA.

Br J Pharmacol. 2012 Jul;166(5):1724-37. doi: 10.1111/j.1476-5381.2012.01882.x.

50.

High-frequency ultrasound for in vivo measurement of colon wall thickness in mice.

Abdelrahman MA, Marston G, Hull MA, Markham AF, Jones PF, Evans JA, Coletta PL.

Ultrasound Med Biol. 2012 Mar;38(3):432-42. doi: 10.1016/j.ultrasmedbio.2011.12.011. Epub 2012 Jan 21.

PMID:
22266235

Supplemental Content

Support Center